Solazyme Inc. (TVIA) Sees Large Volume Increase
Solazyme Inc. (NASDAQ:TVIA) saw unusually-high trading volume on Thursday . Approximately 415,770 shares were traded during trading, an increase of 21% from the previous session’s volume of 343,157 shares.The stock last traded at $2.68 and had previously closed at $2.57.
The company has a 50 day moving average price of $2.49 and a 200 day moving average price of $2.16. The stock’s market capitalization is $230.94 million.
Solazyme (NASDAQ:TVIA) last released its quarterly earnings results on Monday, August 8th. The company reported ($0.26) EPS for the quarter, topping the consensus estimate of ($0.29) by $0.03. The firm had revenue of $9.90 million for the quarter, compared to the consensus estimate of $10.85 million. During the same quarter in the prior year, the company posted $0.40 EPS. The firm’s revenue was down 15.4% on a year-over-year basis. Analysts predict that Solazyme Inc. will post ($1.15) EPS for the current year.
In other news, CFO Tyler Painter sold 12,500 shares of the company’s stock in a transaction dated Tuesday, June 7th. The shares were sold at an average price of $2.67, for a total transaction of $33,375.00. Following the completion of the transaction, the chief financial officer now owns 400,337 shares in the company, valued at $1,068,899.79. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Solazyme, Inc creates renewable oils and bioproducts. The Company’s technology uses microalgae in an industrial fermentation process to transform a range of plant-based sugars into triglyceride oils and other bioproducts. The Company offers Algenist, a skin and personal care product available at Sephora SA and its affiliates, QVC, Inc, SpaceNK Limited, select Nordstrom stores and ULTA Beauty.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.